Trial Profile
A phase II trial evaluated efficacy and safety of Pirfenidone in idiopathic pulmonary fibrosis patients with non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 08 Mar 2016 New trial record